To calculate the dose, use the formula: Units = (Dose in mg Concentration in mg/mL) 100
The risk of gastroparesis is common across the GLP-1RA class, which includes medications like tirzepatide, exenatide, liraglutide, albiglutide, dulaglutide, and lixisenatide
However, recent reports have linked these medications to severe gastrointestinal issues (gastroparesis, intestinal blockages, bowel obstructions, ileus, and pancreatitis) as well as gallbladder problems (gallstones and gallbladder disease)
GLP-1 (glucagon-like peptide-1) slows stomach emptying, promotes feelings of fullness, and stimulates insulin release when blood sugar is high
In addition, acute kidney injury (AKI) has an important impact on the occurrence and development of CKD
Product and Segment View High-Protein Nutrition Products hold a 31.9% share, driven by their essential role in preserving lean muscle mass, enhancing satiety, and offsetting the appetite-suppressing effects of GLP-1 agonists during weight loss therapy